目的:系统评价耐多药肺结核疗效的影响因素,为耐多药肺结核的防治提供参考依据。方法:通过计算机检索、收集中文数据库(中国知网、维普、万方、Sinomed)和英文数据库(Pubmed、Web of science、Medline、Embase、Scopus)中耐多药肺结核...目的:系统评价耐多药肺结核疗效的影响因素,为耐多药肺结核的防治提供参考依据。方法:通过计算机检索、收集中文数据库(中国知网、维普、万方、Sinomed)和英文数据库(Pubmed、Web of science、Medline、Embase、Scopus)中耐多药肺结核疗效影响因素的病例对照研究,检索时限为建库至2023年1月,经筛选和质量评价后使用RevMan 5.4进行Meta分析。结果:最终纳入文献20篇,样本量为7328例。结果显示复治、并发症、不良反应、性别与耐多药肺结核的疗效相关,各因素OR值及其95%CI分别为0.22(0.17~0.29)、0.38(0.32~0.46)、0.27(0.17~0.44)、0.43(0.33~0.56)。结论:并发症、复治、不良反应、男性是耐多药肺结核治疗有效的危险因素,在临床实践中对于不同类型的患者需要更有针对性的措施。受研究数量的限制,上述结论需要更多研究予以论证。展开更多
Objective:To systematically review the influencing factors of the treatment outcome of multidrug-resistant pulmonary tuberculosis and provide reference for the prevention and treatment of multidrug-resistant pulmonary...Objective:To systematically review the influencing factors of the treatment outcome of multidrug-resistant pulmonary tuberculosis and provide reference for the prevention and treatment of multidrug-resistant pulmonary tuberculosis.Method:Case control studies on the factors influencing the treatment outcome of multidrug-resistant pulmonary tuberculosis in Chinese databases(CNKI,VIP,Wanfang,Sinomed)and English databases(Pubmed,Web of science,Medline,Embase,Scopus)were searched and collected by computer.The search period was from the establishment of the database to January 2023.After screening and quality evaluation,RevMan5.4 was used for meta-analysis.Result:Totally 18 articles were ultimately included,with a sample size of 7328 people.The results showed that retreatment,complications,adverse reactions,and gender were related to the treatment outcome of multidrug-resistant pulmonary tuberculosis.The OR values and 95%CI of each factor were 0.22(0.17-0.29),0.38(0.32-0.46),0.27(0.17-0.44),and 0.43(0.33-0.56),respectively.Conclusion:Complications,retreatment,adverse reactions,and male gender are effective risk factors for the treatment outcome of multidrug-resistant pulmonary tuberculosis.In clinical practice,more targeted measures are needed for different types of patients.Due to the limitations of the number of studies,the above conclusions require more research to support them.展开更多
目的研制海口市不同性别、年龄、身高的少年儿童高血压分界值并与全国分界值比较。方法采用整群随机抽样法,抽取海口市29所中小学、227个班的11497名学生,进行人口学信息调查及身高、体质量、血压测量。采用Korotkoff(柯氏)法测定血压,...目的研制海口市不同性别、年龄、身高的少年儿童高血压分界值并与全国分界值比较。方法采用整群随机抽样法,抽取海口市29所中小学、227个班的11497名学生,进行人口学信息调查及身高、体质量、血压测量。采用Korotkoff(柯氏)法测定血压,以柯氏第1音(K1)时的水银血压计示值为收缩压,第5音(K5)时的示值为舒张压。依纳入、排除标准剔除非海口市学生,剔除身高、体质量指数在相同年龄、性别组均数±3倍标准差之外的异常离散样本,获得9100名6~15岁体质量指数、身高正常的少年儿童研究样本及其血压、身高、体质量测量值数列。用R3.2.5软件计算每岁组5%、10%、25%、50%、75%、90%、95%7个身高百分位值(P_(5),P_(10),P_(25),P_(50),P_(75),P_(90),P_(95)),采用位置、形状和范围的广义相加模型(GAMLSS)拟合不同性别、年龄、7个身高百分位点分割成的身高范围,获得相应血压序列的第90、95和99百分位(P_(90),P_(95)和P_(99))血压值。结果制定了海口市不同性别、6~15岁、7个身高范围的少年儿童的正常高值血压、高血压1级、2级的收缩压、舒张压分界值,即各组收缩压和舒张压的P_(90)、P_(95)、P_(99)值。与范晖2017年报道的相同性别、年龄的全国分界值比较,有以下特点:①海口市儿童的平均身高矮,相同百分位身高范围低;②收缩压的P_(90)、P_(95),无论男女,多数年龄组两者相似或海口市的稍高,但男性15岁组,海口市的低4~5 mm Hg;P 99,海口市的要高1~8 mm Hg,但男性15岁组,海口市的低2 mm Hg;③男女各年龄、身高组儿童舒张压的P 90,P 95和P 99,海口市的与全国的差值范围是-1~5 mm Hg。结论海口市6~15岁儿童的高血压分界值有一定的特点,与全国参照标准有一定差别。展开更多
文摘目的:系统评价耐多药肺结核疗效的影响因素,为耐多药肺结核的防治提供参考依据。方法:通过计算机检索、收集中文数据库(中国知网、维普、万方、Sinomed)和英文数据库(Pubmed、Web of science、Medline、Embase、Scopus)中耐多药肺结核疗效影响因素的病例对照研究,检索时限为建库至2023年1月,经筛选和质量评价后使用RevMan 5.4进行Meta分析。结果:最终纳入文献20篇,样本量为7328例。结果显示复治、并发症、不良反应、性别与耐多药肺结核的疗效相关,各因素OR值及其95%CI分别为0.22(0.17~0.29)、0.38(0.32~0.46)、0.27(0.17~0.44)、0.43(0.33~0.56)。结论:并发症、复治、不良反应、男性是耐多药肺结核治疗有效的危险因素,在临床实践中对于不同类型的患者需要更有针对性的措施。受研究数量的限制,上述结论需要更多研究予以论证。
基金Major Science and Technology Projects in Hainan Province(ZDKJ2016008‑02)。
文摘Objective:To systematically review the influencing factors of the treatment outcome of multidrug-resistant pulmonary tuberculosis and provide reference for the prevention and treatment of multidrug-resistant pulmonary tuberculosis.Method:Case control studies on the factors influencing the treatment outcome of multidrug-resistant pulmonary tuberculosis in Chinese databases(CNKI,VIP,Wanfang,Sinomed)and English databases(Pubmed,Web of science,Medline,Embase,Scopus)were searched and collected by computer.The search period was from the establishment of the database to January 2023.After screening and quality evaluation,RevMan5.4 was used for meta-analysis.Result:Totally 18 articles were ultimately included,with a sample size of 7328 people.The results showed that retreatment,complications,adverse reactions,and gender were related to the treatment outcome of multidrug-resistant pulmonary tuberculosis.The OR values and 95%CI of each factor were 0.22(0.17-0.29),0.38(0.32-0.46),0.27(0.17-0.44),and 0.43(0.33-0.56),respectively.Conclusion:Complications,retreatment,adverse reactions,and male gender are effective risk factors for the treatment outcome of multidrug-resistant pulmonary tuberculosis.In clinical practice,more targeted measures are needed for different types of patients.Due to the limitations of the number of studies,the above conclusions require more research to support them.
文摘目的研制海口市不同性别、年龄、身高的少年儿童高血压分界值并与全国分界值比较。方法采用整群随机抽样法,抽取海口市29所中小学、227个班的11497名学生,进行人口学信息调查及身高、体质量、血压测量。采用Korotkoff(柯氏)法测定血压,以柯氏第1音(K1)时的水银血压计示值为收缩压,第5音(K5)时的示值为舒张压。依纳入、排除标准剔除非海口市学生,剔除身高、体质量指数在相同年龄、性别组均数±3倍标准差之外的异常离散样本,获得9100名6~15岁体质量指数、身高正常的少年儿童研究样本及其血压、身高、体质量测量值数列。用R3.2.5软件计算每岁组5%、10%、25%、50%、75%、90%、95%7个身高百分位值(P_(5),P_(10),P_(25),P_(50),P_(75),P_(90),P_(95)),采用位置、形状和范围的广义相加模型(GAMLSS)拟合不同性别、年龄、7个身高百分位点分割成的身高范围,获得相应血压序列的第90、95和99百分位(P_(90),P_(95)和P_(99))血压值。结果制定了海口市不同性别、6~15岁、7个身高范围的少年儿童的正常高值血压、高血压1级、2级的收缩压、舒张压分界值,即各组收缩压和舒张压的P_(90)、P_(95)、P_(99)值。与范晖2017年报道的相同性别、年龄的全国分界值比较,有以下特点:①海口市儿童的平均身高矮,相同百分位身高范围低;②收缩压的P_(90)、P_(95),无论男女,多数年龄组两者相似或海口市的稍高,但男性15岁组,海口市的低4~5 mm Hg;P 99,海口市的要高1~8 mm Hg,但男性15岁组,海口市的低2 mm Hg;③男女各年龄、身高组儿童舒张压的P 90,P 95和P 99,海口市的与全国的差值范围是-1~5 mm Hg。结论海口市6~15岁儿童的高血压分界值有一定的特点,与全国参照标准有一定差别。